Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03221842 |
|---|---|
| Brief Title: | Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients |
| First Submitted : | July 17, 2017 |
| First Submitted that Met QC Criteria : | July 17, 2017 |
| First Posted : | July 19, 2017 |
| Results First Submitted : | November 18, 2021 |
| Results First Posted with QC Comments : | December 17, 2021 |
| Results First Submitted that Met QC Criteria : | December 17, 2021 |
| Results First Posted : | January 18, 2022 |
| Last Update Submitted that Met QC Criteria : | July 25, 2022 |
| Last Update Posted : | July 29, 2022 |